Osamu Kainuma
- Oncology top 2%
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Epidemiology top 10%
- Cancer Research top 5%
- Co-authors
- Akihiro ChoHiroshi YamamotoNobuhiro TakiguchiMatsuo NagataAtsushi IkedaHisashi GunjiAkinari MiyazakiHideaki Shimada
- Topics
- Pancreatic and Hepatic Oncology Research (25 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers)Hepatocellular Carcinoma Treatment and Prognosis (9 papers)
- Partner nations
- JapanUnited StatesTunisia
In The Last Decade
Osamu Kainuma
76 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 1.6k
- Surgery 983
- Pulmonary and Respiratory Medicine 789
- Epidemiology 412
- Cancer Research 310
Countries citing papers authored by Osamu Kainuma
This map shows the geographic impact of Osamu Kainuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Kainuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Kainuma more than expected).
Fields of papers citing papers by Osamu Kainuma
This network shows the impact of papers produced by Osamu Kainuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Kainuma. The network helps show where Osamu Kainuma may publish in the future.
Co-authorship network of co-authors of Osamu Kainuma
This figure shows the co-authorship network connecting the top 25 collaborators of Osamu Kainuma. A scholar is included among the top collaborators of Osamu Kainuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osamu Kainuma. Osamu Kainuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)breakdown → | 742 |
| 2 | 1 | |
| 3 | 7 | |
| 4 | 0 | |
| 5 | 9 | |
| 6 | 1 | |
| 7 | 5 | |
| 8 | 22 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | 17 | |
| 12 | 2 | |
| 13 | 8 | |
| 14 | 1 | |
| 15 | 1 | |
| 16 | 11 | |
| 17 | 1 | |
| 18 | 25 | |
| 19 | 2 | |
| 20 | 5 |
About Osamu Kainuma
Osamu Kainuma is a scholar working on Oncology, Hepatology and Surgery, having authored 80 papers that have together received 2.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (25 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). The work is most often cited by research in Oncology (1.6k citations), Hepatology (243 citations) and Pulmonary and Respiratory Medicine (789 citations). Osamu Kainuma has collaborated with scholars based in Japan, United States and Tunisia. Frequent co-authors include Akihiro Cho, Hiroshi Yamamoto, Nobuhiro Takiguchi, Matsuo Nagata, Atsushi Ikeda, Hisashi Gunji, Akinari Miyazaki, Hideaki Shimada, Hiroaki Soda and Shoichi Hishinuma. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and British journal of surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.